They are not approved by the FDA for medical use, and human or veterinary administration is prohibited
That pressure is what causes the classic symptoms: localized pain, radiating pain down a leg (sciatica) or arm, numbness, tingling, and muscle weakness
Several licensed weight management injectable therapies are available in the UK including semaglutide (Wegovy, approved by NICE for weight management in eligible adults) and tirzepatide (Mounjaro, licensed in the UK for type 2 diabetes and, subject to current NICE guidance, for weight management in eligible adults)
Lancet Diabetes & Endocrinology, 9 (5), 276-292
The advent of compounding pharmacy semaglutide offers a more personalized approach to this medication